MELISSA MECHLER: Open Payments
NPI 1609244854 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,396 in 94 payments from 16 companies in 2025. Trend: 2023 $1,275 · 2024 $1,566 · 2025 $2,396
Food & beverage: $2,396
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $767 |
| Madrigal Pharmaceuticals | 7 | $322 |
| Janssen Biotech, Inc. | 14 | $296 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $209 |
| Lilly USA, LLC | 10 | $175 |
| Novo Nordisk Inc | 3 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $155 |
| QOL Medical, LLC | 2 | $64 |
| Ardelyx, Inc. | 2 | $51 |
| Intercept Pharmaceuticals, Inc. | 2 | $45 |
Products named: REZDIFFRA, TREMFYA, SKYRIZI, ENTYVIO, OMVOH, Wegovy, XIFAXAN, LINZESS.
Industry payments across FL — which companies pay providers there.
